ResearcherJinan Central HospitalNo recent work listed

Yanfei Jia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0670-1604; OpenAlex author ID A5045753153. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper

Papers 1

The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer. Co-author DOI 10.1038/s41388-018-0553-0 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dongsheng Gu · 1 shared paper, 2019 · strength 0.10
- Paper The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer. DOI 10.1038/s41388-018-0553-0 ↗
Beiqin Yu · 1 shared paper, 2019 · strength 0.10
- Paper The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer. DOI 10.1038/s41388-018-0553-0 ↗
Jingwu Xie · 1 shared paper, 2019 · strength 0.10
- Paper The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer. DOI 10.1038/s41388-018-0553-0 ↗
Elena Gabriela Chiorean · 1 shared paper, 2019 · strength 0.10
- Paper The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer. DOI 10.1038/s41388-018-0553-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.